Per Eystein Lønning

Author

Per Eystein Lønning

Also Known As

Ida Bukholm, L S Kolmos, Lars Vatten, Lønning, Per, Lønning, Per E., Lønning, Per Eystein, P E Lonning, P E Lønning, P E L√∏nning, P LONNING

629

Publications

57.5K

Citations

H-Index

163

Concepts

All Affiliations

Haukeland University Hospital University of Bergen University of Oslo Norwegian Cancer Society Oslo University Hospital

About

Per Eystein Lønning is an author at Haukeland University Hospital specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	49	109	25.8K
2	Health Sciences	10	10	2.1K
3	Engineering	6	6	240
4	Natural Sciences	4	4	261
5	Public Health	4	4	130

Per Eystein Lønning

221

Publications

51K

Citations

H-Index

Page 1

	Year	Citations
Molecular portraits of human breast tumours Charles M. Perou, Thérese Sørlie, Michael B. Eisen, Nature Breast OncologyEndocrine-related CancerPathologyBreast CancerMedicine	2000	16.1K
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Thérese Sørlie, Charles M. Perou, Robert Tibshirani, Proceedings of the National Academy of Sciences	2001	10.8K
Repeated observation of breast tumor subtypes in independent gene expression data sets Thérese Sørlie, Robert Tibshirani, Joel S. Parker, Proceedings of the National Academy of Sciences	2003	5.4K
A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer R. Charles Coombes, Emma Hall, Lorna J. Gibson, New England Journal of Medicine	2004	1.8K
Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial R. Charles Coombes, CF Snowdon, Robert Paridaens, The Lancet Tamoxifen TreatmentClinical EffectivenessMedicineClinical TrialsBreast Cancer	2007	905
Subclonal diversification of primary breast cancer revealed by multiregion sequencing Lucy Yates, Moritz Gerstung, Stian Knappskog, Nature Medicine Breast OncologyOncologyTumor HeterogeneityMedicinePathology	2015	815
Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients Turid Aas, Anne‐Lise Børresen, Stephanie Geisler, Nature Medicine Breast OncologyBreast Cancer PatientsMedicinePathologyCancer Genomics	1996	737
Genomic Evolution of Breast Cancer Metastasis and Relapse Lucy Yates, Stian Knappskog, David C. Wedge, Cancer Cell	2017	664
Long-term Cultures of Bone Marrow–Derived Human Mesenchymal Stem Cells Frequently Undergo Spontaneous Malignant Transformation Gro Vatne Røsland, Agnete Svendsen, Anja Torsvik, Cancer Research Cell TherapyStem Cell MigrationStem Cell BiologyTumor BiologyRegenerative Medicine	2009	644
Influence of Letrozole and Anastrozole on Total Body Aromatization and Plasma Estrogen Levels in Postmenopausal Breast Cancer Patients Evaluated in a Randomized, Cross-Over Study Jürgen Geisler, Ben P. Haynes, Gun Anker, Journal of Clinical Oncology	2002	573

Page 1